Shah Pankaj, Vella Adrian, Basu Ananda, Basu Rita, Adkins Aron, Schwenk W Frederick, Johnson C Michael, Nair K Sreekumaran, Jensen Michael D, Rizza Robert A
Endocrine Research Unit, Mayo Clinic, Rochester, Minnesota 55905, USA.
Diabetes. 2003 Jan;52(1):38-42. doi: 10.2337/diabetes.52.1.38.
The present study sought to determine whether elevated plasma free fatty acids (FFAs) alter the splanchnic and muscle glucose metabolism in women. To do so, FFAs were increased in seven women by an 8-h Intralipid/heparin (IL/hep) infusion, and the results were compared with those observed in nine women who were infused with glycerol alone. Glucose was clamped at approximately 8.3 mmol/l and insulin was increased to approximately 300 pmol/l to stimulate both muscle and hepatic glucose uptake. Insulin secretion was inhibited with somatostatin. Leg and splanchnic glucose metabolism were assessed using a combined catheter and tracer dilution approach. The glucose infusion rates required to maintain target plasma glucose concentrations were lower (P < 0.01) during IL/hep than glycerol infusion (30.8 +/- 2.6 vs. 65.0 +/- 7.9 micro mol. kg(-1). min(-1)). Whole-body glucose disappearance (37.0 +/- 2.2 vs. 70.9 +/- 8.7 micro mol. kg(-1). min(-1); P < 0.001) and leg glucose uptake (24.3 +/- 4.2 vs. 59.6 +/- 10.0 micro mol. kg fat-free mass of the leg(-1). min(-1); P < 0.02) were also lower, whereas splanchnic glucose production (8.2 +/- 0.8 vs. 4.3 +/- 0.7 micro mol. kg(-1). min(-1); P < 0.01) was higher during IL/hep than glycerol infusion. We conclude that in the presence of combined hyperinsulinemia and hyperglycemia, elevated FFAs impair glucose metabolism in women by inhibiting whole- body glucose disposal, muscle glucose uptake, and suppression of splanchnic glucose production.
本研究旨在确定血浆游离脂肪酸(FFA)升高是否会改变女性的内脏和肌肉葡萄糖代谢。为此,通过8小时输注英脱利匹特/肝素(IL/hep)使7名女性的FFA升高,并将结果与9名仅输注甘油的女性进行比较。将血糖钳定在约8.3 mmol/l,并将胰岛素增加至约300 pmol/l以刺激肌肉和肝脏对葡萄糖的摄取。用生长抑素抑制胰岛素分泌。使用联合导管和示踪剂稀释法评估腿部和内脏葡萄糖代谢。在IL/hep输注期间,维持目标血浆葡萄糖浓度所需的葡萄糖输注速率低于甘油输注(P < 0.01)(30.8±2.6对65.0±7.9微摩尔·千克-1·分钟-1)。全身葡萄糖消失率(37.0±2.2对70.9±8.7微摩尔·千克-1·分钟-1;P < 0.001)和腿部葡萄糖摄取(24.3±4.2对59.6±10.0微摩尔·腿部无脂肪质量-1·分钟-1;P < 0.02)也较低,而在IL/hep输注期间内脏葡萄糖生成(8.2±0.8对4.3±0.7微摩尔·千克-1·分钟-1;P < 0.01)较高。我们得出结论,在存在高胰岛素血症和高血糖症的情况下,升高的FFA通过抑制全身葡萄糖处置、肌肉葡萄糖摄取和内脏葡萄糖生成来损害女性的葡萄糖代谢。